Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Erratum to: Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis

  • 910 Accesses

  • 2 Citations

Erratum to: Eur J Pediatr (2013) 172:1475–1481

DOI 10.1007/s00431-013-2065-9

The errata are noted below.

Abstract

The sentence, “Liposteroid was intravenously infused at 0.8 mg/kg/day for three consecutive days at the time of acute bleeding.” was corrected to “Liposteroid was intravenously infused at 0.05-0.08 mg (of dexamethasone)/kg/day for three consecutive days at the time of acute bleeding.”

Page 1476, Methods, Liposteroid therapy, line 4-5

The sentence, “It was intravenously infused at 0.8 mg/kg/day for three consecutive days at the time of acute bleeding, after the obtainment of informed consent from parents.” was corrected to “It was intravenously infused at 0.05-0.08 mg (of dexamethasone)/kg/day for three consecutive days at the time of acute bleeding, after the obtainment of informed consent from parents.”

Author information

Correspondence to Shouichi Ohga.

Additional information

The online version of the original article can be found at http://dx.doi.org/10.1007/s00431-013-2065-9.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Doi, T., Ohga, S., Ishimura, M. et al. Erratum to: Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis. Eur J Pediatr 174, 1701 (2015). https://doi.org/10.1007/s00431-015-2638-x

Download citation